The World Health Organization (WHO) confirmed three new deaths from Ebola in the Democratic Republic of Congo.
Two species of bats, as well as humans engaged in hunting these bats in Nagaland, India’s Mimi village, were found to have been exposed to viruses in the family Filoviridae, which includes Ebola and Marburg viruses.
Virus spillover may be occurring between bats and humans in Nagaland, India, according to new research.
Concerns wereraised after a patient's death appears to defy accepted medical theory that survivors of Ebola virus infection are immune to reinfection.
Two treatments for Ebola which were undergoing trials in the Democratic Republic of Congo have been stopped early due to their success in treating Ebola. The two treatments will now be made widely available. One of the drugs is REGN-EB3, a cocktail of three monoclonal antibodies developed by Regeneron Pharmaceuticals. The other drug is mAb114, which is now being developed with Ridgeback Biotherapeutics.
Importing the Ebola virus and other infectious diseases is intended to help strengthen Japan’s inspection system for diseases that have never spread within the country, in preparation for an expected increase in visitors from abroad ahead of the 2020 Tokyo Olympic and Paralympic Games.
The 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo, began on May 8, and was declared over on July 24. Researchers did a retrospective genomic characterization of the outbreak and assessed potential therapeutic agents and vaccines.
The Ebola virus causes a disease that kills up to 90 percent of those who contract it, but a promising vaccine could provide protection.
This study provides the first evidence of Ebola virus-infected survivors from the index site of the west African outbreak. A thorough retrospective epidemiological study done concomitantly among the resident adult population expands understanding of the initiating events including transmission dynamics, probable transmission chains, lower case fatality rates, and the presence of both mild and asymptomatic cases.
A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the Ebola virus in patients and potential treatment pathways. The findings point to a critical role for a molecular pathway that relies on the common nutrient choline, as well as the importance of cellular bodies known as microvesicles.